Cite
HARVARD Citation
Tamborlane, W. et al. (2018). Randomized, double‐blind, placebo‐controlled dose‐finding study of the dipeptidyl peptidase‐4 inhibitor linagliptin in pediatric patients with type 2 diabetes. Pediatric diabetes. 19 (4), pp. 640-648. [Online].